Objective: Antiphospholipid syndrome (APS) or Hughes syndrome is a frequently seen condition in Kuwait that is characterised by the presence of significant titres of a variety of antiphospholipid antibodies (aPL). The main clinical features of this syndrome include thrombosis (both venous and arterial), recurrent fetal wastage and thrombocytopenia. The aim of the present study was to find out the antibodies with a high predictive value for the diagnosis of APS. Methodology: The study included a total of 38 subjects. Nine of them were patients with proven primary APS, 10 with secondary APS and 19 were patients (controls) with weak clinical evidence of APS. After a complete clinical examination and routine investigations, the following categories of aPL were estimated by standard laboratory techniques: anticardiolipin antibodies of IgG and IgM isotypes (GPL and MPL, respectively), anti-ß 2 -glycoprotein-I antibodies (anti-ß 2 -GPI) of IgG and IgM isotypes and activated partial thromboplastin time as a surrogate for lupus anticoagulant (LAC). The tests were considered positive if the titres were more than a standard cut-off value provided by the manufacturer of the kits, and in one instance, the normal range was established in our laboratory (LAC). Results: The highest sensitivity (78.9%) and diagnostic accuracy (71.1%) were obtained by the estimation of GPL. However, excellent specificity (100%) and positive predictive value (100%) with almost as good a diagnostic accuracy (68.4%) were also obtained with anti-ß 2 -GPI of IgG isotype. All the other tests performed poorly when compared with these two. There was no difference in the performance of these tests between primary and secondary APS. Conclusion: Of the various aPL estimated, GPL and anti-ß 2 -GPI of IgG isotype were statistically sensitive and specific investigations for confirming the diagnosis of APS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.